|
Volumn 58, Issue 5 Suppl 1, 2013, Pages
|
A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEUROLEPTIC AGENT;
ANTIPSYCHOTIC LONG-ACTING INJECTIONS;
ARTICLE;
CANADA;
CLASSIFICATION;
CLINICAL PRACTICE;
DELAYED RELEASE FORMULATION;
DEPOT ANTIPSYCHOTICS;
ECONOMICS;
FEMALE;
FIRST-GENERATION ANTIPSYCHOTICS;
FOCUS GROUP;
HEALTH PERSONNEL ATTITUDE;
HUMAN;
INFORMATION PROCESSING;
INTRAMUSCULAR DRUG ADMINISTRATION;
MALE;
MEDICATION COMPLIANCE;
MEDICATION THERAPY MANAGEMENT;
METHODOLOGY;
ORAL DRUG ADMINISTRATION;
PHYSICIAN ATTITUDES;
PSYCHIATRY;
PSYCHOLOGICAL ASPECT;
PSYCHOLOGY;
QUALITATIVE RESEARCH;
SCHIZOPHRENIA;
SECOND-GENERATION ANTIPSYCHOTICS;
STATISTICS;
ANTIPSYCHOTIC LONG-ACTING INJECTIONS;
DEPOT ANTIPSYCHOTICS;
FIRST-GENERATION ANTIPSYCHOTICS;
FOCUS GROUP;
PHYSICIAN ATTITUDES;
SECOND-GENERATION ANTIPSYCHOTICS;
ADMINISTRATION, ORAL;
ANTIPSYCHOTIC AGENTS;
ATTITUDE OF HEALTH PERSONNEL;
CANADA;
DELAYED-ACTION PREPARATIONS;
FEMALE;
FOCUS GROUPS;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
MALE;
MEDICATION ADHERENCE;
MEDICATION THERAPY MANAGEMENT;
PHYSICIAN'S PRACTICE PATTERNS;
PSYCHIATRY;
QUALITATIVE RESEARCH;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
MLCS;
MLOWN;
|
EID: 84884338654
PISSN: 07067437
EISSN: None
Source Type: None
DOI: 10.1177/088740341305805s04 Document Type: Article |
Times cited : (43)
|
References (0)
|